Jones Financial Companies’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
KWM
FCBT
EP
Jones Financial Companies's XPH Position: Q2 2026 in Review
Jones Financial Companies increased its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 16% in Q2 2026, buying an estimated $18.9K and bringing the position to 2,308 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #2692.
Jones Financial Companies first reported a position in XPH in Q2 2013 and has held it in 9 quarters since. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.
- Jones Financial Companies held 2,308 shares of State Street SPDR S&P Pharmaceuticals ETF worth $152K as of Q2 2026.
- Jones Financial Companies bought 323 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2026, an estimated $18.9K.
- State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2692 holding.
- Jones Financial Companies first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and has held it in 9 quarters since.
- 93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.
Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.